Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii
- 1 January 1984
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 78 (3) , 376-379
- https://doi.org/10.1016/0035-9203(84)90126-3
Abstract
Eumycetoma is, at present, treated only by surgery which is amputation at times and mutilating excision at others. Surgical treatment is often followed by local, or rarely distant recurrence to regional lymph nodes and surrounding tissue. The results of the clinical trial with ketoconazole reported in this paper show that five of 13 patients were completely cured and four improved. It is worth noting that the daily dose for those cured was 400 or 300 mg while those who improved were on only 200 mg/day.Keywords
This publication has 6 references indexed in Scilit:
- Laboratory and clinical assessment of ketoconazole in deep-seated mycosesThe American Journal of Medicine, 1983
- Ketoconazole in the treatment of fungal infection: Clinical and laboratory studiesThe American Journal of Medicine, 1983
- Treatment of Systemic Mycoses with Ketoconazole: Emphasis on Toxicity and Clinical Response in 52 PatientsAnnals of Internal Medicine, 1983
- Toxic hepatis during ketoconazole treatment.BMJ, 1981
- Treatment of Paracoccidioidomycosis, Candidiasis, Chromomycosis, Lobomycosis, and Mycetoma with KetoconazoleInternational Journal of Dermatology, 1980
- An Evaluation of Two Years of Clinical Experience with KetoconazoleClinical Infectious Diseases, 1980